Corporate News 14-Jun-24
Lupin's Nagpur facility successfully clears USFDA audit
Lupin announced that the United States Food and Drug Administration (U.S. FDA) has completed an inspection of its Injectable facility in Nagpur, India. The inspection of the facility was carried out from 10 June to 13 June 2024, and concluded with zero 483 observations.
Previous News
Lupin’s Pithampur facility completes USFDA inspection with 3 observations
( Hot Pursuit - 28-Sep-24 14:54 )
Lupin's Pithampur Unit-1 API and finished product facility concludes USFDA inspection
( Corporate News - 28-Sep-24 10:40 )
Lupin allots 5,893 equity shares under ESOP
( Corporate News - 20-Sep-24 12:42 )
Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India
( Hot Pursuit - 18-Sep-24 14:50 )
Lupin enters into patent license agreement with Takeda
( Corporate News - 18-Sep-24 13:43 )
Lupin gains on inking pact to acquire 43% stake in Sunsure Solarpark
( Hot Pursuit - 12-Sep-24 12:26 )
Lupin Ltd soars 1.38%, up for third straight session
( Hot Pursuit - 05-Sep-24 13:05 )
Lupin hits life high on launching overactive bladder drug in US
( Hot Pursuit - 04-Sep-24 15:15 )
Lupin launches Mirabegron Extended-Release Tablets in US
( Corporate News - 04-Sep-24 15:07 )
Lupin allots 1.21 lakh equity shares under ESOP
( Corporate News - 28-Aug-24 18:53 )
Lupin Ltd up for third consecutive session
( Hot Pursuit - 28-Aug-24 13:05 )
Other Stories
Lippi Systems AGM scheduled
28-Sep-24 17:48
SPS Finquest to convene AGM
28-Sep-24 17:48
Emmforce Autotech to hold AGM
28-Sep-24 17:48
Purohit Construction to convene AGM
28-Sep-24 17:48
Rotographics (India) schedules AGM
28-Sep-24 17:47
Jupiter Infomedia to convene AGM
28-Sep-24 17:47
SRG Securities Finance AGM scheduled
28-Sep-24 17:47
Manoj Ceramic to conduct AGM
28-Sep-24 17:47
Sical Logistics to hold AGM
28-Sep-24 17:47
Galaxy Agrico Exports to conduct AGM
28-Sep-24 17:46
Back
Top
